Sunday, July 11, 2021

Tatva Chintan Pharma IPO Date, Review, Price, Form & Market Lot Details

Tatva Chintan Pharma IPO to hit the market on 16 July 2021 and closes on 20 July 2021. The company to raise ₹450 crores via initial public offer. The price band is fixed at ₹1073 to ₹1083 per equity share with face value of ₹10.
 
Tatva Chintan Pharma IPO may hit the market on 16th July 2021. The company to raise ₹450 via initial public offer that comprises ₹225 crore of fresh issue and ₹225 crore of offer for sale. Tatva Chintan Pharma Chem Limited incorporated in 1996 based in Gujarat. They are manufacturer of chestructure directing agents (SDAs), phase transfer catalyst (PTCs), pharmaceutical and agrochemical intermediates, and other specialty chemicals. They are one of the largest manufacturer of SDAs for zeolites in India. The industries they serve are automotive, petroleum, agrochemicals, dyes and pigments, paints and coatings, pharmaceutical, personal care, and others. They provide their products to India and overseas. The export revenues is around 75% and more for the company. They have 2 manufacturing facilities  at Ankleshwar and Dahej in Gujarat. Check out Tatva Chintan Pharma IPO details.

Customers List:
The few of the big names are their customer and the names are Merck, Bayer AG, Ipox Chemicals, Laurus labs, Navin Fluorine International Limited, Atul Limited, Otsuka Chemicals, SRF Limited, Hawks Chemical Company, Firmenich Aromatics Prod Pvt Ltd, and Divi's laboratories.

Tatva Chintan Pharma

Important Details:
Equity Shares outstanding prior to the Issue = 2,00,87,500 Shares
Fresh Issue of 20,77,562 Shares @1,038 = Rs.225 Crores
Offer for Sale of 25,39,242 Shares @1,038 = Rs.275 Crores
Equity Shares outstanding after the Issue = 2,21,65,062 Shares

Category-wise Break up:
Anchor: 13,85,041 Shares = 150.00 Crores
QIB: 9,23,361 Shares = 100.00 Crores
NII: 6,92,521 Shares = 75.00 Crores
RII: 16,15,881 Shares = 175.00  Crores (Lot size: 13 = 1,24,299 Forms)
Total Issue: 46,16,804 Shares = 500.00 Crores

Subscription required for 1X
RII = 1,24,299 Forms
NII = 75 Crores

Financial Information (Basis of Valuation)
The information is collated from the following documents:
RHP = Red Herring Prospectus Dated July 10, 2021 (373 pages)

EPS for FY17-18 >>> Rs.06.12 (Page #89 of DRHP)
EPS for FY18-19 >>> Rs.10.23 (Page #96 of RHP)
EPS for FY19-20 >>> Rs.18.81 (Page #96 of RHP)
EPS for FY20-21 >>> Rs.26.02 (Page #96 of RHP)

RoNW for FY17-18 >>> 20.79% (Page #90 of DRHP)
RoNW for FY18-19 >>> 25.78% (Page #97 of RHP)
RoNW for FY19-20 >>> 32.11% (Page #97 of RHP)
RoNW for FY20-21 >>> 31.49% (Page #97 of RHP)

NAV as on March 31, 2021 was Rs.82.62 (Page #97 of 7RHP)
Advertisement


Listed Industry Peer Group (Page #97 of DRHP):
Aarti Industries
Navin Fluorine International
Alkyl Amines Chemicals
Vinati Organics
Fine Organics Industries

Over Subscription Estimates*:
NII = 20K Crores. = 266.00X*
RII = 20 Lakh Forms = 17.00X* Application wise


    Tatva Chintan Pharma IPO Review

    • Apply with Short Term & Long Term Gain

    Brokerage Firm IPO Reviews

    • Axis Capital: Neutral
    • Capital Market: May Apply
    • Investmentz: Apply
    • KR Choksey Securities: Apply
    • Motilal Oswal: Apply
    • Reliance Securities: Apply
    • Sharekhan: Neutral
    • Ventura Securities: Apply

    Tatva Chintan Pharma IPO Date & Price Band

     IPO Open:  16 July 2021
     IPO Close:  20 July 2021
     IPO Size:  Approx ₹450 Crores
     Fresh Issue:  Approx ₹225 Crores
     Offer for Sale:  Approx ₹225 Crores
     Face Value:  ₹10 Per Equity Share
     Price Band:  ₹1073 to ₹1083 Per Share
     Listing on:  BSE & NSE
     Retail Portion:  35%
     Equity:  - Shares
     Discount:  N/A

    Tatva Chintan Pharma IPO Market Lot

    The Tatva Chintan Pharma IPO minimum market lot is 13 shares with ₹14,079 application amount. The retail investors can apply up-to 13 lots with 182 shares or ₹197,106 amount.
     Minimum Lot Size:  Minimum 13 Shares
     Minimum Amount:  ₹14,079
     Maximum Lot Size:  Maximum 182 Shares
     Maximum Amount:  ₹197,106

    Tatva Chintan Pharma IPO Allotment & Listing

    The Tatva Chintan Pharma IPO date is 16 July 2021 and the close date is 20 July 2021. The allotment date is 26 July 2021 and the IPO to list on 29 July 2021.
     Basis of Allotment:  26 July 2021
     Refunds:  27 July 2021
     Credit to Demat Account:  28 July 2021
     Listing Date:  29 July 2021

    Tatva Chintan Pharma IPO Form

    How to apply the Tatva Chintan Pharma IPO? You can apply Tatva Chintan Pharma IPO via ASBA available in your bank account. Just go to the online bank login and apply via your bank account by selecting the Tatva Chintan Pharma IPO in the Invest section. The other option you can apply Tatva Chintan Pharma IPO via IPO forms download via NSE and BSE. Check out the Tatva Chintan Pharma forms - click NSE Forms & BSE Forms blank IPO forms download, fill and submit in your bank or with your broker.


    Tatva Chintan Pharma Company Financial Report

      ₹ in Crores

    Assets Revenues PAT
    2018 ₹144 ₹137 ₹12.29
    2019 ₹188 ₹207 ₹20.54
    2020 ₹249 ₹267 ₹37.79
    2021 - 9M
    ₹276 ₹195 ₹31.14

    Company Promoters

    • Ajaykumar Mansukhlal Patel
    • Chintan Nitinkumar Shah
    • Snehkar Rasiklal Somani

    About Tatva Chintan Pharma

    We are a specialty chemicals manufacturing company engaged in the manufacture of a diverse portfolio of structure directing agents (“SDAs”), phase transfer catalysts (“PTCs”), electrolyte salts for super capacitor batteries and pharmaceutical and agrochemical intermediates and other specialty chemicals (“PASC”). Our Company is the largest and only commercial manufacturer of SDAs for zeolites in India. It also enjoys the second largest position globally. (Source: F&S Report) In addition, our Company is one of the leading global producers of an entire range of PTCs in India and one of the key producers across the globe. (Source: F&S Report) As a manufacturer of specialty chemicals, we focus on application of our products which form a key ingredient to our customers’ manufacturing and industrial processes. For instance, our SDA and PTC products have various applications in green chemistry, which is pertinent considering the growing focus on green and sustainable technologies. We continuously strive to improve our processes and infrastructure to help reduce our impact on the environment and have accordingly, undertaken various ‘green’ chemistry processes such as electrolysis. Considering the wide application of our products, we serve customers across various industries, including the automotive, petroleum, pharmaceutical, agro chemicals, paints and coatings, dyes and pigments, personal care and flavour and fragrances industries. Apart from our customers in India, we also export our products to over 25 countries, including the USA, China, Germany, Japan, South Africa, and the UK.

    Our Company is promoted by Chintan Shah, Ajay Patel and Shekhar Somani, who each have over 24 years in the specialty chemicals manufacturing industry and have established strong business relationships with domestic as well as overseas customers. In addition, we are led by a well – qualified and experienced management team, which we believe has demonstrated its ability to manage and grow our operations and has substantial experience in the sectors in which we operate. We believe that the knowledge and experience of our management team provides us with a significant competitive advantage as we seek to grow our business.

    Quick Links

    DRHP Draft Prospectus
    RHP Draft Prospectus

    Tatva Chintan Pharma IPO Registrar

    Link Intime India Private Ltd
    C 101, 247 Park, L.B.S.Marg,
    Vikhroli (West), Mumbai - 400083
    Phone: +91-22-4918 6270
    Email: tatva.ipo@linkintime.co.in
    Website: http://www.linkintime.co.in
    Note: Check Tatva Chintan Pharma IPO allotment status on Linkintime website allotment URL. Click Here

    Tatva Chintan Pharma IPO Lead Managers

    • ICICI Securities Ltd
    • JM Financial Consultants Private Limited

    Company Address

    Tatva Chintan Pharma Chem Limited
    Plot No. 502 / 17, GIDC Estate, Ankleshwar,
    Bharuch, Gujarat - 393002, India
    Phone: +91 75730 46951
    Email: cs@tatvachintan.com
    Website: http://www.tatvachintan.com/

    Tatva Chintan Pharma IPO FAQs


    What is Tatva Chintan Pharma IPO?

    Tatva Chintan Pharma IPO is a main-board IPO. They are going to raise ₹450 Crores via IPO. The issue is priced at ₹1073 to ₹1083 per equity share. The IPO to list on BSE & NSE.

    When Tatva Chintan Pharma IPO will open?

    The IPO is to open on 16 July 2021 for QIB, NII, and Retail Investors.

    What is Tatva Chintan Pharma IPO Investors Portion?

    The investors' portion for QIB 50%, NII 15%, and Retail 35%.

    How to Apply the Tatva Chintan Pharma IPO?

    You can apply Tatva Chintan Pharma IPO via ASBA online via your bank account. You can also apply ASBA online via UPI through your stock brokers. You can also apply via your stock brokers by filling up the offline form.

    How to Apply the Tatva Chintan Pharma IPO through Zerodha?

    Log in to Console in Zerodha Website or in Application. Go to Portfolio and Click on IPO. You will see the IPO Name "Tatva Chintan Pharma". Click on Bid Button. Enter your UPI ID, Quantity and Price. Submit IPO Application Form. Now go to your UPI App on Net Banking or BHIM App to Approve the mandate. Open Demat Account with Zerodha.

    How to Apply the Tatva Chintan Pharma IPO through Upstox?

    Log in to Upstox Application with your credentials. Select the IPO. You will see the IPO Name "Tatva Chintan Pharma". Click on Bid Button. Confirm your application. Now go to your UPI App on Net Banking or BHIM App to Approve the mandate. Open Demat Account with Upstox.

    What is Tatva Chintan Pharma IPO Size?

    Tatva Chintan Pharma IPO size is ₹450 crores.

    What is Tatva Chintan Pharma IPO Price Band?

    Tatva Chintan Pharma IPO Price Band is ₹1073 to ₹1083.

    What is Tatva Chintan Pharma IPO Minimum and Maximum Lot Size?

    The minimum bid is 13 Shares with ₹14,079 amount while maximum bid is 182 shares with ₹197,106.

    What is Tatva Chintan Pharma IPO Allotment Date?

    Tatva Chintan Pharma IPO allotment date is 26 July 2021.

    What is Tatva Chintan Pharma IPO Listing Date?

    Tatva Chintan Pharma IPO listing date is 29 July 2021. The IPO to list on BSE and NSE.

    Note: The Tatva Chintan Pharma IPO details added as it is officially announced. The IPO grey market premium (Tatva Chintan Pharma IPO Premium) started. You can check our IPO grey market page for daily updates.